Archive: 03/09/2014

Fast-tracking rare disease drug candidates' approval

Aspiring new drugs face long and stringent tests on safety and effectiveness before making it to market. And rightly so. But giving drugs special designations that bring with them the right incentives can help bring them ...

page 7 from 8